Table 7.

The analysis of the clinical features of the recurrence of CDI in two patients before and after initiation of LP299v prophylaxis. The above-mentioned periods lasted twelve months.

	Before LP299v Use	After LP299v Use
Duration of diarrhoea (days)	28 ± 37	9.5 ± 9
Number of stools per a day during CDI symptoms	8 ± 0	7 ± 0
Abdominal pain (n)	2	2
Vomiting (n)	0	0
Fever (n)	2	2
Average leucocytes count (G/L) during CDI symptoms	14.1 ± 9.9	14.4 ± 13.1
Average CRP serum concentrations (mg/L) during CDI symptoms	96.5 ± 34.7	43.8 ± 43.5